Purchase Order 75N93023P01227

Award Date 9/7/23
Potential Completion Date 12/29/23
Potential Value $170K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $30,539 firm fixed price purchase order to 10X Genomics, Inc. for the acquisition of Chromium Next GEM Single Cell 5' Kits and Library Construction Kits. Under the terms of the contract, 10X Genomics will provide 16 reactions of the Chromium Next GEM Single Cell 5' Kit v2 and 48 reactions of the Library Construction Kit. The place of performance is 10X...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,889.50 firm fixed price purchase order to 10X Genomics, Inc. for 10X Genomics Chromium Next Gem products. The place of performance will be 10X Genomics' facilities in Pleasanton, California, with work expected to be completed by February 14, 2024. As the National Institute of Allergy and Infectious Diseases conducts research on preventing, diagnosing and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,229 firm fixed price purchase order to 10X Genomics, Inc. for CHROMIUM NEXTGEM SINGLE CELL KITS. Under this contract, 10X Genomics will provide its single cell analysis kits to support genomic research being conducted at its Pleasanton, California location. No subcontractors or set aside designations were identified. This purchase is consistent with...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,514 purchase order to 10X Genomics, Inc. for the delivery of a CHROMIUM NEXT GEM KIT (AMBIS #2184796). Performance will take place in Pleasanton, California over approximately two months, concluding on November 30, 2023. The firm fixed price contract supports the delivery of the specified next generation sequencing kit to the agency. 10X Genomics will...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 purchase order to 10X Genomics, Inc. for the delivery of chromium next generation multiplex kits. As part of its broader biomedical research efforts, the funding agency supports genomic research initiatives including those utilizing 10X Genomics' single-cell analysis technologies. No subcontractors or set aside designations were identified. The firm...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order valued at $161,700.90 to 10X Genomics, Inc. for Chromium Next GEM reagents. The contract has a period of performance from July 10, 2023 through September 29, 2023. The solicitation requested 10X Genomics brand name supplies including Chromium Next GEM Single Cell ATAC Kits, Chromium Single Cell Human TCR and BCR Amplification...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $12,306.50 firm fixed-price purchase order to 10X Genomics, Inc., located in Pleasanton, California, to provide Chromium Kits. The contract period of performance runs from August 28, 2023 through August 27, 2024. 10X Genomics will deliver its Chromium Kits to support the NIH's research efforts in the areas of allergy and infectious disease. No...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $22,167.50 firm fixed-price purchase order to 10X Genomics, Inc. for chromium and library construction kits. The place of performance is Pleasanton, California, and the period of performance is August 24, 2023 through October 2, 2023. 10X Genomics will deliver the requested kits to support the NIH NIAID's research efforts. No major subcontractors or set...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 firm fixed price purchase order to 10X Genomics, Inc. for CHROMIUM NEXT GEM KITS. 10X Genomics will deliver the kits from its Pleasanton, California location under a September to October 2023 period of performance. The National Institute of Allergy and Infectious Diseases supports research on preventing, diagnosing and treating infectious and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,846.50 firm fixed price purchase order to 10X Genomics, Inc. for CHROMIUM NEXT GEM REAGENT KITS (AMBIS #2183246). Performance will take place in Pleasanton, California over approximately six weeks concluding in mid-October 2023. The award is for specified reagent kits to support genomic research activities. 10X Genomics will serve as the prime contractor...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $169,774 firm fixed price purchase order to 10X Genomics, Inc. for CHROMIUM NEXTGEM SINGLE CELL REAGENT KITS. The place of performance is 10X Genomics' Pleasanton, California facility. The period of performance is from September 7, 2023 through December 29, 2023. This contract has a total small business set aside designation. 10X Genomics will deliver its CHROMIUM NEXTGEM SINGLE CELL REAGENT KITS to support the National Institute of Allergy and Infectious Diseases' research efforts to better understand disease at the single cell level.

Generated 12/19/23, 8:49 PM